Celebi John
SEC CIK 1843539 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| FTH | Faeth Therapeutics, Inc. | Pres, CEO, Dir | 105.9K | $425 | — | 7 | 2022-02-15 | 2025-02-19 |
Most active insiders at FTH, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | MILLENNIUM MANAGEMENT LLC | 10% | $1.34M | $704.5K |
| 2 | STEPHENSON BRIAN C | CFO | $1.13M | — |
| 3 | Peyer James | 10%, See remarks below | — | $787.8K |
| 4 | Cambrian BioPharma Inc | 10% | — | $787.8K |
| 5 | Parikh Anand Kiran | Pres, CEO, Dir | $55.4K | — |
| 6 | Hahn Stephen M. | Dir | — | — |
Celebi John made no open-market trades at FTH in the last 12 months.
Transactions 7
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-26 | 2025-02-19 | FTH | Faeth Therapeutics, Inc. | Celebi John | Pres AND CEO, Dir | F - Tax | $0.48 | -5,558 | 105.9K | -5% | -$2,668 | |
| D | 2024-02-16 | 2024-02-15 | FTH | Faeth Therapeutics, Inc. | Celebi John | Pres AND CEO, Dir | F - Tax | $0.79 | -5,891 | 105.4K | -5% | -$4,654 |
| 2023-09-13 | 2023-09-11 | FTH | Faeth Therapeutics, Inc. | Celebi John | Pres, CEO, Dir | P - Purchase | $0.85 | +500 | 111.3K | +0.5% | +$425 | |
| 2023-09-11 | 2023-02-15 | FTH | Faeth Therapeutics, Inc. | Celebi John | Pres, CEO, Dir | F - Tax | $1.50 | -20.5K | 110.8K | -16% | -$30.7K | |
| DMA | 2023-03-29 | 2023-02-15 | FTH | Faeth Therapeutics, Inc. | Celebi John | Pres, CEO, Dir | A - Grant | $0.00 | +73.2K | 110.0K | +199% | $0 |
| DM | 2023-02-17 | 2023-02-15 | FTH | Faeth Therapeutics, Inc. | Celebi John | Pres, CEO, Dir | A - Grant | $0.00 | +73.2K | 106.0K | +223% | $0 |
| D | 2022-02-17 | 2022-02-15 | FTH | Faeth Therapeutics, Inc. | Celebi John | Pres, CEO, Dir | A - Grant | $0.00 | +53.9K | 54.1K | +25,187% | $0 |
Purchase Sale Sale after option exercise All abbreviations